EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES EGX:PHAR:
EIPICO 9-MONTH CONSOL NET PROFIT ATTRIBUTABLE EGP 1.09 BILLION
EIPICO 9-MONTH CONSOL REVENUE EGP 7.16 BILLION
EIPICO 9-Month Consol Profit EGP 1.09 Billion
Egyptian International Pharmaceutical Industries Co. on 6ix
Later from Egyptian International Pharmaceutical Industries
- EIPICO Says EIPICO 3 Facility Gets Final Operating License From Egyptian Drug Authority
- Eipico FY Shareholders' Dividend EGP 590.6 Million
Follow Egyptian International Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Egyptian International Pharmaceutical Industries